Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.28
+0.39 (1.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
HRMY Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 681.88 | 582.02 | 437.86 | 305.44 | 159.74 | 6 | Upgrade
|
| Revenue Growth (YoY) | 25.83% | 32.93% | 43.35% | 91.21% | 2564.59% | - | Upgrade
|
| Cost of Revenue | 145.56 | 121.24 | 83.48 | 55.52 | 27.74 | 1.58 | Upgrade
|
| Gross Profit | 536.32 | 460.79 | 354.37 | 249.92 | 132 | 4.42 | Upgrade
|
| Selling, General & Admin | 219.56 | 192.69 | 163.3 | 132.03 | 95.57 | 80.73 | Upgrade
|
| Research & Development | 141.47 | 76.06 | 70.89 | 30.37 | 19.45 | 69.6 | Upgrade
|
| Operating Expenses | 361.03 | 268.76 | 234.19 | 162.39 | 115.02 | 150.32 | Upgrade
|
| Operating Income | 175.3 | 192.03 | 120.19 | 87.53 | 16.99 | -145.9 | Upgrade
|
| Interest Expense | -18.08 | -23.76 | -18.8 | -24.19 | -28.62 | -6.07 | Upgrade
|
| Interest & Investment Income | 18.16 | 14.73 | 3.13 | 0.22 | 0.4 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.04 | 0.16 | 0.17 | 0.02 | -3.07 | - | Upgrade
|
| EBT Excluding Unusual Items | 175.34 | 183.16 | 104.69 | 63.57 | -14.31 | -151.98 | Upgrade
|
| Other Unusual Items | - | -9.77 | - | -26.15 | -22.64 | - | Upgrade
|
| Pretax Income | 175.34 | 173.4 | 104.69 | 37.43 | -36.94 | -151.98 | Upgrade
|
| Income Tax Expense | 52.71 | 44.54 | -76.78 | 2.83 | - | - | Upgrade
|
| Net Income | 122.63 | 128.85 | 181.47 | 34.6 | -36.94 | -151.98 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 26.9 | 35.23 | Upgrade
|
| Net Income to Common | 122.63 | 128.85 | 181.47 | 34.6 | -63.85 | -187.21 | Upgrade
|
| Net Income Growth | -18.66% | -28.99% | 424.52% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 57 | 59 | 59 | 58 | 26 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 60 | 61 | 59 | 26 | 8 | Upgrade
|
| Shares Change (YoY) | -5.01% | -1.19% | 3.20% | 129.72% | 231.37% | -12.19% | Upgrade
|
| EPS (Basic) | 2.14 | 2.17 | 3.07 | 0.60 | -2.48 | -24.07 | Upgrade
|
| EPS (Diluted) | 2.11 | 2.13 | 2.97 | 0.58 | -2.48 | -24.07 | Upgrade
|
| EPS Growth | -14.80% | -28.28% | 412.07% | - | - | - | Upgrade
|
| Free Cash Flow | 220.18 | 219.08 | 144.29 | 98.26 | -2.99 | -75.59 | Upgrade
|
| Free Cash Flow Per Share | 3.79 | 3.63 | 2.36 | 1.66 | -0.12 | -9.72 | Upgrade
|
| Gross Margin | 78.65% | 79.17% | 80.93% | 81.82% | 82.64% | 73.69% | Upgrade
|
| Operating Margin | 25.71% | 32.99% | 27.45% | 28.66% | 10.63% | -2433.76% | Upgrade
|
| Profit Margin | 17.98% | 22.14% | 41.44% | 11.33% | -39.97% | -3122.74% | Upgrade
|
| Free Cash Flow Margin | 32.29% | 37.64% | 32.95% | 32.17% | -1.87% | -1260.80% | Upgrade
|
| EBITDA | 199.56 | 216.39 | 143.57 | 106.37 | 27.22 | -142.69 | Upgrade
|
| EBITDA Margin | 29.27% | 37.18% | 32.79% | 34.82% | 17.04% | - | Upgrade
|
| D&A For EBITDA | 24.27 | 24.36 | 23.39 | 18.84 | 10.24 | 3.21 | Upgrade
|
| EBIT | 175.3 | 192.03 | 120.19 | 87.53 | 16.99 | -145.9 | Upgrade
|
| EBIT Margin | 25.71% | 32.99% | 27.45% | 28.66% | 10.63% | - | Upgrade
|
| Effective Tax Rate | 30.06% | 25.69% | - | 7.56% | - | - | Upgrade
|
| Advertising Expenses | - | 21.54 | 22.43 | 19.56 | 13.3 | 7.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.